(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are PAVmed, Spectra Energy, and Quanterix Corporation.

The three biggest losers today are Rubius Therapeutics, Performance Shipping, and BlackBerry.

Winners today

1. PAVmed (PAVMW) – 105.67%

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.

NASDAQ ended the session with PAVmed jumping 105.67% to $0.03 on Tuesday, after five successive sessions in a row of losses. NASDAQ slid 1.25% to $11,530.33, following the last session’s downward trend on what was an all-around down trend trading session today.

Moving Average

PAVmed’s worth is way under its 50-day moving average of $0.21 and way below its 200-day moving average of $1.66.

Volume

Today’s last reported volume for PAVmed is 32626 which is 397.12% above its average volume of 6563.

More news about PAVmed.

2. Spectra Energy (SE) – 22.4%

Sea Limited, together with its subsidiaries, engages in the digital entertainment, e-commerce, and digital financial service businesses in Southeast Asia, Latin America, rest of Asia, and internationally. It offers Garena digital entertainment platform for users to access mobile and PC online games, as well as eSports operations; and access to other entertainment content, including livestreaming of gameplay and social features, such as user chat and online forums. The company also operates Shopee e-commerce platform, a mobile-centric marketplace that provides integrated payment and logistics infrastructure and seller services. In addition, it offers SeaMoney digital financial services to individuals and businesses, including offline and online mobile wallet, and payment processing services, as well as other offerings across credit, insurtech, and digital bank services under the ShopeePay, SPayLater, SeaBank, and other digital financial services brands; and payment processing services for Shopee. The company was formerly known as Garena Interactive Holding Limited and changed its name to Sea Limited in April 2017. Sea Limited was incorporated in 2009 and is headquartered in Singapore.

NYSE ended the session with Spectra Energy jumping 22.4% to $80.43 on Tuesday while NYSE slid 1.6% to $15,443.48.

Earnings Per Share

As for profitability, Spectra Energy has a trailing twelve months EPS of $-3.39.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.25%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Spectra Energy’s stock is considered to be oversold (<=20).

More news about Spectra Energy.

3. Quanterix Corporation (QTRX) – 12.13%

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

NASDAQ ended the session with Quanterix Corporation rising 12.13% to $13.59 on Tuesday while NASDAQ fell 1.25% to $11,530.33.

Earnings Per Share

As for profitability, Quanterix Corporation has a trailing twelve months EPS of $-2.94.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.7%.

Volume

Today’s last reported volume for Quanterix Corporation is 537194 which is 77.36% above its average volume of 302874.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 14.5% and 10.2%, respectively.

Previous days news about Quanterix Corporation

• Quanterix corporation (qtrx) reports Q4 loss, misses revenue estimates. According to Zacks on Monday, 6 March, "While Quanterix Corporation has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Quanterix Corporation.

4. Seanergy Maritime Holdings Corp (SHIPW) – 10%

NASDAQ ended the session with Seanergy Maritime Holdings Corp rising 10% to $0.03 on Tuesday while NASDAQ slid 1.25% to $11,530.33.

PE Ratio

Seanergy Maritime Holdings Corp has a trailing twelve months price to earnings ratio of 0.21. Meaning, the purchaser of the share is investing $0.21 for every dollar of annual earnings.

Yearly Top and Bottom Value

Seanergy Maritime Holdings Corp’s stock is valued at $0.03 at 16:32 EST, under its 52-week high of $0.03 and above its 52-week low of $0.03.

More news about Seanergy Maritime Holdings Corp.

5. American Public Education (APEI) – 7.54%

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education. The company operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. It offers 130 degree programs and 111 certificate programs in various fields of study, including business administration, health science, technology, criminal justice, education, and liberal arts, as well as national security, military studies, intelligence, and homeland security. The company also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, an associate degree in nursing, and an associate degree in medical laboratory technology. American Public Education, Inc. was incorporated in 1991 and is headquartered in Charles Town, West Virginia.

NASDAQ ended the session with American Public Education rising 7.54% to $11.13 on Tuesday, following the last session’s upward trend. NASDAQ dropped 1.25% to $11,530.33, following the last session’s downward trend on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, American Public Education has a trailing twelve months EPS of $1.25.

PE Ratio

American Public Education has a trailing twelve months price to earnings ratio of 8.9. Meaning, the purchaser of the share is investing $8.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.53%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 134% and a negative 67.9%, respectively.

Yearly Top and Bottom Value

American Public Education’s stock is valued at $11.13 at 16:32 EST, way under its 52-week high of $24.02 and way higher than its 52-week low of $7.83.

More news about American Public Education.

6. Solid Biosciences (SLDB) – 5.01%

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Solid Biosciences jumping 5.01% to $5.45 on Tuesday while NASDAQ dropped 1.25% to $11,530.33.

Earnings Per Share

As for profitability, Solid Biosciences has a trailing twelve months EPS of $-1.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.79%.

Sales Growth

Solid Biosciences’s sales growth for the next quarter is 14.3%.

Volume

Today’s last reported volume for Solid Biosciences is 22797 which is 18.88% below its average volume of 28103.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 31.2% and 71.5%, respectively.

Moving Average

Solid Biosciences’s value is way below its 50-day moving average of $6.54 and way under its 200-day moving average of $8.05.

More news about Solid Biosciences.

7. Canaan (CAN) – 4.98%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components primarily in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has a strategic cooperation with Northern Data AG in the areas of artificial intelligence development, blockchain technology, and datacenter operations. Canaan Inc. was founded in 2013 and is based in Beijing, the People's Republic of China.

NASDAQ ended the session with Canaan jumping 4.98% to $2.64 on Tuesday, following the last session’s downward trend. NASDAQ fell 1.25% to $11,530.33, following the last session’s downward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.212.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.53%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 25.8%, now sitting on 6.17B for the twelve trailing months.

Volatility

Canaan’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.84%, a negative 1.58%, and a positive 4.78%.

Canaan’s highest amplitude of average volatility was 3.77% (last week), 3.99% (last month), and 4.78% (last quarter).

Moving Average

Canaan’s value is under its 50-day moving average of $2.75 and way below its 200-day moving average of $3.19.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be overbought (>=80).

More news about Canaan.

8. Stitch Fix (SFIX) – 4.82%

Stitch Fix, Inc. sells a range of apparel, shoes, and accessories through its Website and mobile application in the United States. It offers denim, dresses, blouses, skirts, shoes, jewelry, and handbags for men, women, and kids under the Stitch Fix brand. The company was formerly known as rack habit inc. and changed its name to Stitch Fix, Inc. in October 2011. Stitch Fix, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.

NASDAQ ended the session with Stitch Fix jumping 4.82% to $5.00 on Tuesday, following the last session’s downward trend. NASDAQ dropped 1.25% to $11,530.33, following the last session’s downward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, Stitch Fix has a trailing twelve months EPS of $-0.871.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -67.55%.

Volume

Today’s last reported volume for Stitch Fix is 2275150 which is 21.95% below its average volume of 2915190.

Moving Average

Stitch Fix’s worth is way above its 50-day moving average of $4.31 and under its 200-day moving average of $5.04.

Revenue Growth

Year-on-year quarterly revenue growth declined by 21.6%, now sitting on 1.95B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 21.4% and positive 55.6% for the next.

More news about Stitch Fix.

9. SiNtx Technologies (SINT) – 4.2%

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

NASDAQ ended the session with SiNtx Technologies jumping 4.2% to $2.72 on Tuesday, after two successive sessions in a row of losses. NASDAQ slid 1.25% to $11,530.33, following the last session’s downward trend on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, SiNtx Technologies has a trailing twelve months EPS of $-1.083.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -67.57%.

Yearly Top and Bottom Value

SiNtx Technologies’s stock is valued at $2.72 at 16:32 EST, way under its 52-week high of $70.80 and way higher than its 52-week low of $2.18.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 22.1% and 57.8%, respectively.

More news about SiNtx Technologies.

10. Research Solutions (RSSS) – 4.17%

Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.

NASDAQ ended the session with Research Solutions jumping 4.17% to $2.25 on Tuesday while NASDAQ dropped 1.25% to $11,530.33.

Earnings Per Share

As for profitability, Research Solutions has a trailing twelve months EPS of $-0.03.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.31%.

More news about Research Solutions.

Losers Today

1. Rubius Therapeutics (RUBY) – -37.5%

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Rubius Therapeutics sliding 37.5% to $0.04 on Tuesday while NASDAQ dropped 1.25% to $11,530.33.

Earnings Per Share

As for profitability, Rubius Therapeutics has a trailing twelve months EPS of $-2.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -164.53%.

More news about Rubius Therapeutics.

2. Performance Shipping (PSHG) – -15.14%

Performance Shipping Inc., through its subsidiaries, provides shipping transportation services through its ownership of tanker vessels worldwide. It owned and operated five Aframax tanker vessels with a combined carrying capacity of 546,094 dwt. The company was incorporated in 2010 and is based in Athens, Greece.

NASDAQ ended the session with Performance Shipping falling 15.14% to $0.94 on Tuesday while NASDAQ fell 1.25% to $11,530.33.

Earnings Per Share

As for profitability, Performance Shipping has a trailing twelve months EPS of $1.25.

PE Ratio

Performance Shipping has a trailing twelve months price to earnings ratio of 0.75. Meaning, the purchaser of the share is investing $0.75 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.87%.

Sales Growth

Performance Shipping’s sales growth for the current quarter is negative 45.3%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 187.8%, now sitting on 75.17M for the twelve trailing months.

More news about Performance Shipping.

3. BlackBerry (BB) – -12.03%

BlackBerry Limited provides intelligent security software and services to enterprises and governments worldwide. The company operates through three segments: Cybersecurity, IoT, and Licensing and Other. The company offers BlackBerry Cyber Suite, which provides Cylance AI and machine learning-based cybersecurity solutions, including BlackBerry Protect, an EPP and available MTD solution; BlackBerry Optics, an EDR solution that provides visibility into and prevention of malicious activity; BlackBerry Guard, a managed detection and response solution; BlackBerry Gateway, an AI-empowered ZTNA solution; and BlackBerry Persona, a UEBA solution that provides authentication by validating user identity in real time. It also provides BlackBerry Spark Unified Endpoint Management Suite, such as BlackBerry UEM, a central software component of its secure communications platform; BlackBerry Dynamics that provides a development platform and secure container for mobile applications; BlackBerry AtHoc and BlackBerry Alert secure and networked critical event management solutions; and SecuSUITE for Government, a multi-OS voice and text messaging solution, as well as BBM Enterprise, an enterprise-grade secure instant messaging solution. In addition, the company offers BlackBerry QNX, which provides Neutrino operating system and BlackBerry QNX CAR platform, and other products; BlackBerry QNX, an embedded system solution; BlackBerry Jarvis, a cloud-based binary static application security testing platform; BlackBerry Certicom cryptography and management products, and BlackBerry Radar asset monitoring solution; and BlackBerry IVY, an intelligent vehicle data platform, as well as enterprise and cybersecurity consulting services. Further, it is involved in the patent licensing and legacy service access fees business. As of February 28, 2022, it owned approximately 38,000 worldwide patents and applications. BlackBerry Limited was incorporated in 1984 and is headquartered in Waterloo, Canada.

NYSE ended the session with BlackBerry sliding 12.03% to $3.51 on Tuesday while NYSE slid 1.6% to $15,443.48.

Earnings Per Share

As for profitability, BlackBerry has a trailing twelve months EPS of $-1.97.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.78%.

Volume

Today’s last reported volume for BlackBerry is 15264900 which is 121.93% above its average volume of 6877940.

Volatility

BlackBerry’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.04%, a negative 0.58%, and a positive 2.58%.

BlackBerry’s highest amplitude of average volatility was 2.91% (last week), 2.35% (last month), and 2.58% (last quarter).

Moving Average

BlackBerry’s worth is way under its 50-day moving average of $6.10 and way below its 200-day moving average of $8.33.

More news about BlackBerry.

4. The Pennant Group (PNTG) – -10.27%

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

NASDAQ ended the session with The Pennant Group falling 10.27% to $13.98 on Tuesday while NASDAQ slid 1.25% to $11,530.33.

Earnings Per Share

As for profitability, The Pennant Group has a trailing twelve months EPS of $0.23.

PE Ratio

The Pennant Group has a trailing twelve months price to earnings ratio of 60.78. Meaning, the purchaser of the share is investing $60.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.04%.

More news about The Pennant Group.

5. RumbleOn (RMBL) – -9%

RumbleON, Inc. operates a technology-based omnichannel platform to aggregate and distribute pre-owned vehicles in North America. It operates through three segments: Powersports, Automotive, and Vehicle Logistics. The Powersports segment distributes motorcycles. The Automotive segment distributes cars and trucks. The Vehicle Logistics segment provides automotive transportation services between dealerships and auctions. Its platform offers ability to buy, sell, trade, and finance new and pre-owned vehicles online or in store for dealers and consumers. The company was formerly known as Smart Server, Inc. and changed its name to RumbleON, Inc. in February 2017. RumbleON, Inc. was incorporated in 2013 and is based in Irving, Texas.

NASDAQ ended the session with RumbleOn sliding 9% to $8.09 on Tuesday while NASDAQ fell 1.25% to $11,530.33.

Earnings Per Share

As for profitability, RumbleOn has a trailing twelve months EPS of $7.49.

PE Ratio

RumbleOn has a trailing twelve months price to earnings ratio of 1.08. Meaning, the purchaser of the share is investing $1.08 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.41%.

Moving Average

RumbleOn’s value is below its 50-day moving average of $8.29 and way below its 200-day moving average of $14.18.

Volume

Today’s last reported volume for RumbleOn is 201920 which is 25.54% above its average volume of 160833.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 110.4% and a negative 50%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 112.6%, now sitting on 1.92B for the twelve trailing months.

More news about RumbleOn.

6. PainReform Ltd. (PRFX) – -8.32%

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

NASDAQ ended the session with PainReform Ltd. falling 8.32% to $0.55 on Tuesday, following the last session’s downward trend. NASDAQ dropped 1.25% to $11,530.33, following the last session’s downward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, PainReform Ltd. has a trailing twelve months EPS of $-0.686.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.74%.

Yearly Top and Bottom Value

PainReform Ltd.’s stock is valued at $0.55 at 16:32 EST, way below its 52-week high of $1.74 and way higher than its 52-week low of $0.34.

More news about PainReform Ltd..

7. MicroVision (MVIS) – -7.64%

MicroVision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module that can support AR headsets; Interactive Display modules used in smart speakers and other devices; and Consumer Lidar used in smart home systems. In addition, it provides PicoP, a scanning technology that creates full color, high-contrast, and uniform image over the entire field-of-view from a small and thin module. Further, the company develops 1st generation long range lidar. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

NASDAQ ended the session with MicroVision falling 7.64% to $2.24 on Tuesday, following the last session’s downward trend. NASDAQ fell 1.25% to $11,530.33, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, MicroVision has a trailing twelve months EPS of $-0.102.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -50.24%.

Volume

Today’s last reported volume for MicroVision is 1399500 which is 29.41% below its average volume of 1982740.

Volatility

MicroVision’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.48%, a negative 1.89%, and a positive 3.71%.

MicroVision’s highest amplitude of average volatility was 4.41% (last week), 3.49% (last month), and 3.71% (last quarter).

Moving Average

MicroVision’s value is way under its 50-day moving average of $2.60 and way under its 200-day moving average of $3.62.

Sales Growth

MicroVision’s sales growth is negative 10.2% for the present quarter and 14.3% for the next.

More news about MicroVision.

8. Qurate Retail (QRTEA) – -7.28%

Qurate Retail, Inc., together with its subsidiaries, engages in the video and online commerce industries in North America, Europe, and Asia. The company markets and sells various consumer products primarily through merchandise-focused televised shopping programs, Internet, and mobile applications. It also operates as an online retailer offering women's, children's, and men's apparel; and other products, such as home, accessories, and beauty products through its app, mobile, and desktop applications. The company serves approximately 200 million homes worldwide. The company was formerly known as Liberty Interactive Corporation and changed its name to Qurate Retail, Inc. in April 2018. Qurate Retail, Inc. was founded in 1991 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Qurate Retail falling 7.28% to $1.40 on Tuesday while NASDAQ fell 1.25% to $11,530.33.

Earnings Per Share

As for profitability, Qurate Retail has a trailing twelve months EPS of $-6.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -144.23%.

More news about Qurate Retail.

9. Castle Biosciences (CSTL) – -7.17%

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.

NASDAQ ended the session with Castle Biosciences sliding 7.17% to $22.54 on Tuesday while NASDAQ slid 1.25% to $11,530.33.

Earnings Per Share

As for profitability, Castle Biosciences has a trailing twelve months EPS of $-1.24.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.86%.

Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $22.54 at 16:32 EST, way below its 52-week high of $48.40 and way above its 52-week low of $15.58.

More news about Castle Biosciences.

10. PetIQ (PETQ) – -7.05%

PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

NASDAQ ended the session with PetIQ dropping 7.05% to $10.95 on Tuesday while NASDAQ slid 1.25% to $11,530.33.

Earnings Per Share

As for profitability, PetIQ has a trailing twelve months EPS of $-2.37.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.82%.

More news about PetIQ.

Stay up to date with our winners and losers daily report